首页> 美国卫生研究院文献>other >Redefining the structure-activity relationships of 26-methano-3-benzazocines. Part 9: Synthesis characterization and molecular modeling of pyridinyl isosteres of N-BPE-8-CAC (1) a high affinity ligand for opioid receptors
【2h】

Redefining the structure-activity relationships of 26-methano-3-benzazocines. Part 9: Synthesis characterization and molecular modeling of pyridinyl isosteres of N-BPE-8-CAC (1) a high affinity ligand for opioid receptors

机译:重新定义的26-二甲基 - 3- benzazocines的结构 - 活性关系。 9部分:合成表征和吡啶基的分子建模的N- BpE-8-CaC(1)中阿片样物质受体的高亲和性配体的等排物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Derivatives of the lead compound N-BPE-8-CAC (>1) where each CH of the biphenyl group was individually replaced by N were prepared in hopes of identifying high affinity ligands with improved aqueous solubility. Compared to >1, binding affinities of the five possible pyridinyl derivatives for the μ opioid receptor were between 3-fold lower to 5-fold higher with the Ki of the most potent compound being 0.064 nM. Docking of 8-CAC (>2) into the unliganded binding site of the mouse μ opioid receptor (pdb: 4DKL) revealed that 8-CAC and β-FNA (from 4DKL) make nearly identical interactions with the receptor. However, for >1 and the new pyridinyl derivatives >4–>8, binding is not tolerated in the 8-CAC binding mode due to the steric constraints of the large N-substituents. Either an alternative binding mode or rearrangement of the protein to accommodate these modifications may account for their high binding affinity.
机译:制备了先导化合物N-BPE-8-CAC(> 1 )的衍生物,其中联苯基的每个CH均被N取代,以期鉴定具有改善的水溶性的高亲和力配体。与> 1 相比,五种可能的吡啶基衍生物与μ阿片受体的结合亲和力低3倍至5倍,而最有效化合物的Ki值为0.064 nM。将8-CAC(> 2 )对接至小鼠μ阿片受体(pdb:4DKL)的未配体结合位点,发现8-CAC和β-FNA(来自4DKL)与该蛋白发生了几乎相同的相互作用。受体。但是,对于> 1 和新的吡啶基衍生物> 4 – > 8 ,由于空间限制,在8-CAC结合模式下不容许结合较大的N取代基。替代的结合模式或蛋白质的重排以适应这些修饰均可解释其高结合亲和力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号